Early outcomes comparing induction with antithymocyte globulin vs alemtuzumab in two steroid-avoidance protocols in pediatric renal transplantation.
Puliyanda, Dechu P
Early outcomes comparing induction with antithymocyte globulin vs alemtuzumab in two steroid-avoidance protocols in pediatric renal transplantation. [electronic resource] - Pediatric transplantation 05 2020 - e13685 p. digital
Publication Type: Clinical Trial; Comparative Study; Journal Article; Multicenter Study
1399-3046
10.1111/petr.13685 doi
Adolescent
Alemtuzumab--therapeutic use
Antilymphocyte Serum--therapeutic use
Child
Child, Preschool
Drug Therapy, Combination
Female
Graft Rejection--prevention & control
Humans
Immunosuppressive Agents--therapeutic use
Induction Chemotherapy--methods
Infant
Infant, Newborn
Kidney Transplantation
Male
Steroids
Treatment Outcome
Early outcomes comparing induction with antithymocyte globulin vs alemtuzumab in two steroid-avoidance protocols in pediatric renal transplantation. [electronic resource] - Pediatric transplantation 05 2020 - e13685 p. digital
Publication Type: Clinical Trial; Comparative Study; Journal Article; Multicenter Study
1399-3046
10.1111/petr.13685 doi
Adolescent
Alemtuzumab--therapeutic use
Antilymphocyte Serum--therapeutic use
Child
Child, Preschool
Drug Therapy, Combination
Female
Graft Rejection--prevention & control
Humans
Immunosuppressive Agents--therapeutic use
Induction Chemotherapy--methods
Infant
Infant, Newborn
Kidney Transplantation
Male
Steroids
Treatment Outcome